Italy · Delayed Price · Currency is EUR Esprinet Statistics
Total Valuation
Esprinet has a market cap or net worth of EUR 326.57 million. The enterprise value is 685.20 million.
| Market Cap | 326.57M |
| Enterprise Value | 685.20M |
Important Dates
The last earnings date was Wednesday, May 13, 2026.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | May 4, 2026 |
Share Statistics
Esprinet has 49.44 million shares outstanding. The number of shares has increased by 0.25% in one year.
| Current Share Class | 49.44M |
| Shares Outstanding | 49.44M |
| Shares Change (YoY) | +0.25% |
| Shares Change (QoQ) | +7.81% |
| Owned by Insiders (%) | 11.60% |
| Owned by Institutions (%) | 6.24% |
| Float | 28.65M |
Valuation Ratios
The trailing PE ratio is 14.35 and the forward PE ratio is 12.29.
| PE Ratio | 14.35 |
| Forward PE | 12.29 |
| PS Ratio | 0.07 |
| PB Ratio | 0.83 |
| P/TBV Ratio | 1.26 |
| P/FCF Ratio | 10.49 |
| P/OCF Ratio | 9.22 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.21, with an EV/FCF ratio of 22.02.
| EV / Earnings | 30.44 |
| EV / Sales | 0.16 |
| EV / EBITDA | 9.21 |
| EV / EBIT | 13.70 |
| EV / FCF | 22.02 |
Financial Position
The company has a current ratio of 1.26, with a Debt / Equity ratio of 1.31.
| Current Ratio | 1.26 |
| Quick Ratio | 0.67 |
| Debt / Equity | 1.31 |
| Debt / EBITDA | 6.90 |
| Debt / FCF | 16.48 |
| Interest Coverage | 3.24 |
Financial Efficiency
Return on equity (ROE) is 5.76% and return on invested capital (ROIC) is 5.40%.
| Return on Equity (ROE) | 5.76% |
| Return on Assets (ROA) | 1.65% |
| Return on Invested Capital (ROIC) | 5.40% |
| Return on Capital Employed (ROCE) | 8.03% |
| Weighted Average Cost of Capital (WACC) | 5.40% |
| Revenue Per Employee | 2.44M |
| Profits Per Employee | 12,507 |
| Employee Count | 1,800 |
| Asset Turnover | 2.32 |
| Inventory Turnover | 6.27 |
Taxes
In the past 12 months, Esprinet has paid 12.43 million in taxes.
| Income Tax | 12.43M |
| Effective Tax Rate | 35.58% |
Stock Price Statistics
The stock price has increased by +58.77% in the last 52 weeks. The beta is 1.20, so Esprinet's price volatility has been higher than the market average.
| Beta (5Y) | 1.20 |
| 52-Week Price Change | +58.77% |
| 50-Day Moving Average | 5.71 |
| 200-Day Moving Average | 5.74 |
| Relative Strength Index (RSI) | 57.04 |
| Average Volume (20 Days) | 546,934 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Esprinet had revenue of EUR 4.39 billion and earned 22.51 million in profits. Earnings per share was 0.46.
| Revenue | 4.39B |
| Gross Profit | 240.31M |
| Operating Income | 50.02M |
| Pretax Income | 34.95M |
| Net Income | 22.51M |
| EBITDA | 58.91M |
| EBIT | 50.02M |
| Earnings Per Share (EPS) | 0.46 |
Balance Sheet
The company has 154.36 million in cash and 512.99 million in debt, with a net cash position of -358.63 million or -7.25 per share.
| Cash & Cash Equivalents | 154.36M |
| Total Debt | 512.99M |
| Net Cash | -358.63M |
| Net Cash Per Share | -7.25 |
| Equity (Book Value) | 392.41M |
| Book Value Per Share | 8.31 |
| Working Capital | 339.20M |
Cash Flow
In the last 12 months, operating cash flow was 35.41 million and capital expenditures -4.29 million, giving a free cash flow of 31.12 million.
| Operating Cash Flow | 35.41M |
| Capital Expenditures | -4.29M |
| Depreciation & Amortization | 8.89M |
| Net Borrowing | -45.37M |
| Free Cash Flow | 31.12M |
| FCF Per Share | 0.63 |
Margins
Gross margin is 5.47%, with operating and profit margins of 1.14% and 0.51%.
| Gross Margin | 5.47% |
| Operating Margin | 1.14% |
| Pretax Margin | 0.80% |
| Profit Margin | 0.51% |
| EBITDA Margin | 1.34% |
| EBIT Margin | 1.14% |
| FCF Margin | 0.71% |
Dividends & Yields
This stock pays an annual dividend of 0.35, which amounts to a dividend yield of 5.27%.
| Dividend Per Share | 0.35 |
| Dividend Yield | 5.27% |
| Dividend Growth (YoY) | -12.50% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 87.85% |
| Buyback Yield | -0.25% |
| Shareholder Yield | 5.02% |
| Earnings Yield | 6.89% |
| FCF Yield | 9.53% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Esprinet is 7.80, which is 18.09% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 7.80 |
| Price Target Difference | 18.09% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on May 16, 2005. It was a forward split with a ratio of 10.
| Last Split Date | May 16, 2005 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
Esprinet has an Altman Z-Score of 2.71 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.71 |
| Piotroski F-Score | 7 |